ABBV · 10-Q · 2026Q2 · Full report
Outstanding Indebtedness
AbbVie Inc. · 2026-08-03 · Importance 33 · Surprise 42 · Matches filing data
AbbVie issued $8.0 billion of unsecured senior notes during the six months ended June 30, 2026. The company repaid $2.0 billion of its 364-day term loan credit agreement and $2.0 billion of 3.20% senior notes during the same period. AbbVie had no commercial paper outstanding at June 30, 2026, compared with $499 million at December 31, 2025. Subsequent to quarter-end, AbbVie established a $10.0 billion 364-day senior unsecured term loan facility for the proposed Apogee acquisition, but had drawn none as of the filing date.
Key facts
- Financing cash flows for the six months ended June 30, 2026 included issuance of unsecured senior notes totaling $8.0 billion aggregate principal, repayment of $2.0 billion aggregate principal of the 364-day term loan credit agreement and repayment of $2.0 billion aggregate principal of 3.20% senior notes. source
- Interest expense for the six months ended June 30, 2026: $1,440 million; interest income: $(135) million; interest expense, net: $1,305 million. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| liability | negative | realized | -5.9% | Financing cash flows for the six months ended June 30, 2026 included issuance of unsecured senior notes totaling $8.0 billion aggregate… |
| cash | positive | realized | +5.9% | Financing cash flows for the six months ended June 30, 2026 included issuance of unsecured senior notes totaling $8.0 billion aggregate… |
| liability | positive | realized | +3.0% | Financing cash flows for the six months ended June 30, 2026 included issuance of unsecured senior notes totaling $8.0 billion aggregate… |
| cash | negative | realized | -3.0% | Financing cash flows for the six months ended June 30, 2026 included issuance of unsecured senior notes totaling $8.0 billion aggregate… |